C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/88 (2006.01) C07H 21/04 (2006.01)
Patent
CA 2569046
Human ALDO genes are identified as modulators of the IGF pathway, and thus are therapeutic targets for disorders associated with defective IGF function. Methods for identifying modulators of IGF, comprising screening for agents that modulate the activity of ALDO are provided.
L'invention concerne des gènes ALDO humains qui ont été identifiés comme modulateurs de la voie de signalisation IGF et qui constituent par conséquent des cibles thérapeutiques pour des troubles associés à une fonction IGF déficiente. L'invention porte sur des procédés d'identification de modulateurs de l'IGF, qui consistent à cribler des agents modulant l'activité des gènes ALDO.
Heuer Timothy S.
Hitz Benjamin C.
Maxwell Mark E.
Ollmann Michael Martin
Bennett Jones Llp
Exelixis Inc.
LandOfFree
Aldos as modifiers of the igf pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aldos as modifiers of the igf pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldos as modifiers of the igf pathway and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1406112